scPharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview

Scpharmaceuticals

17/03/2023 12:36

* scPharmaceuticals Inc  SCPH.OQ   SCPH.O  is expected
to show no
change in quarterly revenue when it reports  results on March
22. 
    * 
    * ​Refinitiv's mean analyst estimate for scPharmaceuticals
Inc is
for a loss of 39 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $14​, above​ its last closing price of $7.23. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.36       -0.38      -0.37     Beat    3.3
 Jun. 30 2022  -0.30       -0.30      -0.35     Missed  -15.4
 Mar. 31 2022  -0.32       -0.31      -0.28     Beat    9.7​
 Dec. 31 2021  -0.32       -0.34      -0.27     Beat    21.4
 ​​Sep.        -0.31       -0.31      -0.24     Beat    23.4
 30 2021                                                
 Jun. 30 2021  -0.30       -0.30      -0.26     Beat    13.3​
 Mar. 31 2021  -0.30       -0.30      -0.26     Beat    13.3
 Dec. 31 2020  -0.36       -0.36      -0.28     Beat    22.9
 This summary was machine generated March 17 at 12:36 GMT.  All
figures in US dollars  unless otherwise stated